TELA Bio Files 2024 Annual Report

Ticker: TELA · Form: 10-K · Filed: Mar 21, 2025 · CIK: 1561921

Tela Bio, Inc. 10-K Filing Summary
FieldDetail
CompanyTela Bio, Inc. (TELA)
Form Type10-K
Filed DateMar 21, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, financials

TL;DR

TELA Bio's 2024 10-K is in. Check retained earnings and paid-in capital for 23/24.

AI Summary

TELA Bio, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting on its financial condition and business operations. The company, incorporated in Delaware, is based in Malvern, PA, and operates in the surgical and medical instruments sector. Key financial data points such as retained earnings and additional paid-in capital for both 2023 and 2024 are detailed within the filing.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of TELA Bio's financial performance and position as of December 31, 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — The filing is a standard annual report, but the company operates in the medical device industry which carries inherent regulatory and market risks.

Key Numbers

  • 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
  • 2023-12-31 — Prior Fiscal Year End (Comparative period for financial data)

Key Players & Entities

  • TELA Bio, Inc. (company) — Filer of the 10-K
  • 2024-12-31 (date) — Fiscal year end
  • Malvern, PA (location) — Company headquarters
  • DE (location) — State of incorporation
  • 001-39130 (dollar_amount) — SEC File Number

FAQ

What were TELA Bio's retained earnings as of December 31, 2024?

As of December 31, 2024, TELA Bio's retained earnings were reported.

What was the company's additional paid-in capital on December 31, 2023?

The filing indicates that TELA Bio's additional paid-in capital as of December 31, 2023, is a reported figure.

What is TELA Bio's primary business sector?

TELA Bio, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, with SIC code 3841.

Where is TELA Bio, Inc. headquartered?

TELA Bio, Inc. is headquartered at 1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA 19355.

When was this 10-K filing submitted?

This 10-K filing was submitted on March 21, 2025.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 21, 2025 regarding TELA Bio, Inc. (TELA).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.